Travere Therapeutics (TVTX) Goodwill (2014 - 2025)

Travere Therapeutics' (TVTX) quarterly Goodwill came in at $800000.0 in Q3 2025, little changed YoY from $800000.0 in Q3 2024, and little changed on a QoQ basis from $800000.0 in Q2 2025.

Travere Therapeutics (TVTX) Goodwill (2014 - 2025) Analysis & Trends

Travere Therapeutics (TVTX) has 12 years of Goodwill data on file, last reported at $800000.0 in Q3 2025.

  • Quarterly Goodwill changed 0.0% year-over-year to $800000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $800000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $800000.0, changed 0.0% from the prior year.
  • Goodwill held at $800000.0 in Q3 2025, from $800000.0 in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $936000.0 in Q1 2021 to a low of $800000.0 in Q4 2022.
  • A 5-year average of $853052.6 and a median of $800000.0 in 2022 frame the typical range for Goodwill.
  • Annual changes were most pronounced in 2021 — Goodwill changed 0.0% — and 2022, when it slipped 11.11%.
  • Tracing TVTX's Goodwill over 5 years: stood at $900000.0 in 2021, then retreated by 11.11% to $800000.0 in 2022, then changed by 0.0% to $800000.0 in 2023, then changed by 0.0% to $800000.0 in 2024, then changed by 0.0% to $800000.0 in 2025.
  • The last three Goodwill figures came in at $800000.0 (Q3 2025), $800000.0 (Q2 2025), and $800000.0 (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Travere Therapeutics 5.85 Bn 5.85 Bn 162.52 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 800,000.00
Jun 30, 2025 800,000.00
Mar 31, 2025 800,000.00
Dec 31, 2024 800,000.00
Sep 30, 2024 800,000.00
Jun 30, 2024 800,000.00
Mar 31, 2024 800,000.00
Dec 31, 2023 800,000.00
Sep 30, 2023 800,000.00
Jun 30, 2023 900,000.00
Mar 31, 2023 900,000.00
Dec 31, 2022 800,000.00
Sep 30, 2022 900,000.00
Jun 30, 2022 900,000.00
Mar 31, 2022 900,000.00
Dec 31, 2021 900,000.00
Sep 30, 2021 936,000.00
Jun 30, 2021 936,000.00
Mar 31, 2021 936,000.00
Dec 31, 2020 900,000.00